A practical reference on MC4R agonist: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2025-10-30 and is reviewed periodically as new material appears.
Handling procedures emphasize minimizing moisture uptake, since the dried solid is hygroscopic and can draw water when warmed to room temperature before a vial is opened. Laboratories record lot number, purity, counter-ion content, and residual solvent data supplied by the producer. Impurity profiles are compared run to run, and any shift in retention time or peak shape prompts re-verification against a reference standard. Certificates of analysis are treated as claims to be checked rather than accepted at face value.
Identity and purity testing for this peptide typically relies on reversed-phase high-performance liquid chromatography with ultraviolet detection, reported as area-percent purity. Mass spectrometry, usually in tandem mode, confirms molecular mass and supports quantification in biological matrices. Sequence confirmation may use peptide mapping after enzymatic digestion, while nuclear magnetic resonance and circular dichroism supply supplementary structural detail. No single technique establishes identity alone, so laboratories compare retention time, mass, and fragment pattern against a verified reference standard.
Development began with intranasal formulations investigated for erectile dysfunction, but blood pressure elevation limited that route and prompted a switch to subcutaneous delivery. Clinical testing then shifted toward hypoactive sexual desire disorder in premenopausal women, and a subcutaneous product received United States approval in 2019. Later trials examined other populations with mixed results, and questions about effect size, durability and patient selection remain open in the peer-reviewed literature. Research interest continues in parallel with the broader melanocortin field, where several synthetic analogues are studied together.
PT-141 is the research code for bremelanotide, a cyclic heptapeptide derived from alpha-melanocyte-stimulating hormone. The molecule belongs to the melanocortin receptor agonist family and shows highest affinity for the MC4 receptor subtype, with weaker activity at MC1, MC3 and MC5. Its structure retains the core His-Phe-Arg-Trp sequence that defines melanocortin recognition, while cyclization and terminal modifications improve metabolic stability relative to the parent hormone. Early work classified the compound as a centrally acting agent rather than a peripherally acting vasodilator, which shaped subsequent development priorities.
Receptor activation in hypothalamic and limbic circuits is the mechanism most often cited for the observed effects on sexual desire. Signalling through MC4R couples to Gs proteins and raises intracellular cyclic AMP, which in turn modulates dopaminergic tone in reward-related pathways. Because the peptide reaches the central nervous system after subcutaneous administration, peripheral vascular changes are regarded as secondary rather than primary. The precise neural circuits that translate receptor occupancy into behavioural change remain incompletely mapped, and published accounts describe the pathway in general terms rather than as a fully resolved sequence.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white solid | Lyophilized powder form |
| Solubility class | Freely soluble in water | Also dissolves in polar organic solvents |
| Typical storage temperature | Minus 20 degrees Celsius or lower | Desiccated and protected from light |
| Typical analytical method | Reversed-phase HPLC with UV detection | Purity reported by area normalization |
| Common synonyms | PT-141; bremelanotide | Research code and assigned generic name |
After subcutaneous administration, plasma concentrations rise within roughly thirty minutes and the elimination half-life is short, on the order of two to three hours. Reported physiological responses include transient increases in blood pressure and nausea, which tended to diminish with repeated dosing in trial settings. Because the peptide clears quickly, effects are not expected to persist long after a dose. Absorption from non-injected routes is poorly characterised, and nasal delivery produced variable plasma levels in older work.
Clinical research typically uses randomised, double-blind, placebo-controlled designs. The most common primary endpoint is the desire domain score of the Female Sexual Function Index, sometimes paired with a distress measure. Secondary outcomes include arousal, satisfaction, and event-based counts of satisfying sexual episodes. Across trials, average improvements are modest and individual responses vary widely. Whether benefits persist beyond a few months, and whether they depend on baseline hormone status, remain open questions rather than settled findings.
Melanocortin receptors form a family of five G-protein-coupled receptors designated MC1 through MC5. Bremelanotide binds most strongly at MC4R and MC1R, with weaker activity reported at MC3R and MC5R. MC4R is expressed in hypothalamic nuclei that coordinate energy balance and aspects of sexual behaviour. The prevailing interpretation is that central MC4R activation, rather than peripheral vascular effects alone, drives the reported changes in desire. This account remains partly inferential, since direct receptor-level measurement in living humans is not practical.
PT-141 is the research designation for bremelanotide, a synthetic cyclic heptapeptide developed as a melanocortin receptor agonist. The peptide contains seven amino acids with an internal lactam bridge that constrains the backbone into a stable ring. Cyclisation of this kind improves resistance to enzymatic degradation relative to linear analogues. The compound was first explored for effects on melanin production, because several melanocortin receptors influence pigmentation. Its later association with sexual desire emerged from observations made during that early work, and the molecule became the subject of a separate development programme.
Bremelanotide is a moderately large peptide with a molecular mass near 1025 daltons. In lyophilised form it appears as a white to off-white powder and is freely soluble in water and other polar solvents. The intact lactam ring is essential for receptor affinity, while linearised fragments bind far more weakly. Solutions are sensitive to extremes of pH and to prolonged exposure to light and heat, so handling typically involves buffered conditions and cold storage. Its short plasma half-life reflects rapid distribution and clearance rather than chemical breakdown inside the vial.
Bremelanotide is a cyclic heptapeptide that binds several melanocortin receptors rather than one. In vitro assays report agonist activity at MC1R, MC3R, MC4R and MC5R, with MC4R generally treated as the subtype most relevant to sexual effects. MC4R is expressed in hypothalamic nuclei involved in appetite, energy balance and motivated behaviour, which provides a plausible route for central action. Selective MC4R agonists studied in animals produce comparable behavioural changes, supporting that interpretation.
How receptor activation translates into a change in desire is not established in detail. Proposed steps include modulation of dopaminergic signalling in reward circuits and downstream effects on autonomic tone. Human data consist mainly of clinical trials measuring self-reported outcomes rather than direct measurements of brain activity or transmitter release. The transient rise in blood pressure sometimes observed after administration is likewise reported consistently but explained only partly by known melanocortin pathways.
Melanocortin receptors form a family of five G-protein-coupled proteins, labelled MC1R through MC5R, that respond to peptides derived from pro-opiomelanocortin. Alpha-melanocyte-stimulating hormone and adrenocorticotropic hormone are the best-known endogenous ligands. The receptors are distributed differently across tissues, so a single agonist can produce effects in the brain, skin, adrenal gland and vasculature. This distribution explains why one peptide can influence both pigmentation and motivated behaviour.
population, Sanders stated that "we must end global oligarchy" and that "we need, in the United States and throughout the world, a tax system which is fair, progressive and transparent." On September 5, 2018, Sanders partnered with Ro Khanna to introduce the Stop Bad Employers by Zeroing Out Subsidies (Stop BEZOS) Act, which would require large corporations to pay for the food stamps and Medicaid benefits that their employees receive, relieving the burden on taxpayers.
After the unbound probes are washed away, the Western blot is ready for detection of the probes that are labeled and bound to the protein of interest. In practical terms, not all Westerns reveal protein only at one band in a membrane. Size approximations are taken by comparing the stained bands to that of the marker or ladder loaded during electrophoresis. The process is commonly repeated for a structural protein, such as actin or tubulin, that should not change between samples. The amount of target protein is normalized to the structural protein to control between groups. A superior strategy is the normalization to the total protein visualized with trichloroethanol or epicocconone. This practice ensures correction for the amount of total protein on the membrane in case of errors or incomplete transfers. (see Western blot normalization)
=== A balanced nervous system === In the balanced nervous system with required cognitive functions, the sympathetic (SNS) and parasympathetic nervous systems (PNS) operate in synergy while opposing each other. Stimulation of the SNS boosts body activity and attention: it raises heart rate and blood pressure. In contrast, stimulation of the PNS is the rest-and-digest state: it reduces blood pressure and heart rate. The nervous system interplays with the immune system. Through these interactions, the nervous and immune systems ensure the nervous system maintains immune homeostasis.
== Demise == The Arab League – led by Egypt – set up the All-Palestine Government (an Egyptian protectorate) in Gaza on 8 September 1948, while the 1948 Arab–Israeli War was in progress, under the nominal leadership of Amin al-Husayni, which was soon recognized by six of the seven Arab League members, the exception being Transjordan. King Abdullah of Transjordan regarded the attempt to revive al-Husayni's Holy War Army as a challenge to his authority and all armed bodies operating in the areas controlled by the Arab Legion were ordered to disband. Glubb Pasha carried out the order ruthlessly and efficiently. After the war, the Arab Higher Committee was politically irrelevant, and banned from the Jordanian West Bank, as was the All-Palestine Government.
== Toxicity and deficiency == There is an optimal range of selenium concentration in animals (or broadly speaking, in almost every selenium-dependent lifeform). Too much results in toxicity, too little results in deficiency.
Sources: en.wikipedia.org
=== Overdose === Alitretinoin is a form of vitamin A. Alitretinoin has been administered in oncological clinical studies at dosages of more than 10-times of the therapeutic dosage given for chronic hand eczema. The adverse effects observed were consistent with retinoid toxicity, and included severe headache, diarrhoea, facial flushing and hypertriglyceridemia. These effects were reversible.
=== Receiver details === In addition to triggering the broadcast signal, the output of the transmitter trigger signal was also sent to the receiver hut. Here it fed the input to a time base generator that drove the X-axis deflection plates of the CRT display. This caused the electron beam in the tube to start moving left-to-right at the instant that the transmission was completed. Due to the slow decay of the pulse, some of the transmitted signal was received on the display. This signal was so powerful it overwhelmed any reflected signal from targets, which meant that objects closer than about 5 miles (8.0 km) could not be seen on the display. To reduce this period even to this point required the receiver to be hand-tuned, selecting the decoupling capacitors and impedance of the power supplies. The receiver system, built by A.C. Cossor to a TRE design, was a multiple-stage superheterodyne. The signal from the selected antennas on the receiver towers was fed through the radiogoniometer and then into a three-stage amplifier, with each stage housed in a metal screen box to avoid interference between the stages. Each stage used a Class B amplifier arrangement of EF8s, special low noise, "aligned-grid" pentodes. The output of the initial amplifier was then sent to the intermediate frequency mixer, which extracted a user-selectable amount of the signal, 500, 200 or 50 kHz as selected by a switch on the console. The first setting allowed most of the signal through, and was used under most circumstances.
In number theory, the crank of a partition is a certain integer associated with the partition. Dyson first introduced the term without a definition in a 1944 paper in a journal published by the Mathematics Society of Cambridge University. He then gave a list of properties this yet-to-be-defined quantity should have. In 1988, George E. Andrews and Frank Garvan discovered a definition for the crank satisfying the properties Dyson had hypothesized.
=== Potassium === Potassium levels can fluctuate severely during the treatment of DKA, because insulin decreases potassium levels in the blood by redistributing it into cells via increased sodium-potassium pump activity. A large part of the shifted extracellular potassium would have been lost in urine because of osmotic diuresis. Hypokalemia (low blood potassium concentration) often follows treatment. This increases the risk of dangerous irregularities in the heart rate. Therefore, continuous observation of the heart rate is recommended, as well as repeated measurement of the potassium levels and addition of potassium to the intravenous fluids once levels fall below 5.3 mmol/L. If potassium levels fall below 3.3 mmol/L, insulin administration may need to be interrupted to allow correction of the hypokalemia.
Sources: en.wikipedia.org
=== Mental health === Mental health side effects have been reported. These symptoms are rare but exist in significant enough numbers to include as potential side effects. These include depression, anxiety, irritability, nightmares, and psychotic reactions.
=== Other uses === As a generic software platform, DHIS2 has been adapted for a variety of use cases both within and beyond the health sector. In addition to the most common uses listed above, examples of known DHIS2 projects include water and sanitation, nutrition and food security, agriculture and land management, and e-governance.
He intended for the new Hibiscus to be open by September, and to transfer over the style of cooking he had used in Ludlow, saying, "I'm transferring Hibiscus, not starting a new restaurant. The idea is to continue and build on what I have been doing." Purchasing and fitting out the London premises cost around £1 million. Many of the staff from the Ludlow incarnation of Hibiscus agreed to move to London to continue working at the restaurant, including head chef Marcus McGuinness and sommelier Simon Freeman. Hibiscus re-opened in October 2007 in its new location after following building works and planning delays. The interior of the London-based restaurant was decorated in orange and shades of brown. The walls were covered in pale-coloured wooden panels, and a chandelier designed as a series of globes hungs from the middle of the main dining room's ceiling. The handover on the first day was so tight that builders moved out at midday, and the first service was run at 7 pm that evening. The late opening resulted in the reviewers for the Michelin Guide having only a two-week window in which to re-assess the restaurant for the 2008 guide. Bosi admitted later that the restaurant was not yet up to scratch in those two weeks and agreed with the decision of Michelin to downgrade Hibiscus to a single star in the 2008 Guide. The restaurant was also given a "rising star" as one with potential to go up to two stars in the future. During the run up to Christmas, the stress of serving 550 covers a week in a new location with a modified menu resulted in three sous chefs resigning.
Sources: en.wikipedia.org
Chemical degradation such as hydrolysis and oxidation proceeds more slowly as temperature falls. Cold storage also limits microbial growth in reconstituted material. Repeated warming should be avoided because thermal cycling stresses the peptide.
Retention time supports consistency but does not establish structure by itself. A different compound can elute at a similar time under one set of conditions. Mass spectrometry or comparison with a verified standard is normally required alongside the chromatographic result.
The lactam bridge constrains the peptide backbone and limits attack by some exopeptidases. It does not protect against hydrolysis of amide bonds inside the ring or against oxidative modification of susceptible residues. Stability therefore still depends heavily on storage conditions.
The code designates bremelanotide, a cyclic heptapeptide melanocortin receptor agonist. It served as an internal research identifier before the compound entered formal clinical development. The code and the generic name refer to the same molecule.